NCT03278509View on ClinicalTrials.gov

Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

5,000

Participants

Timeline

Start Date

September 11, 2017

Primary Completion Date

November 16, 2023

Study Completion Date

December 31, 2025

Conditions
Acute Myocardial InfarctionNon-ST Elevation Myocardial InfarctionST Elevation Myocardial Infarction
Interventions
DRUG

Metoprolol Succinate

Eligible patients randomized to active treatment will receive long-term oral beta-blockade (metoprolol succinate or bisoprolol).

DRUG

Bisoprolol

Please see the section above.

Trial Locations (1)

182 88

Danderyd Hospital, Cardiac Intensive Care, Danderyd

All Listed Sponsors
collaborator

Uppsala University

OTHER

collaborator

The Swedish Research Council

OTHER_GOV

lead

Karolinska Institutet

OTHER